{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:11:18Z","timestamp":1793067078157,"version":"4.5.0"},"reference-count":123,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007620","name":"Department of Education of Liaoning Province","doi-asserted-by":"publisher","award":["JYTMS20230628"],"award-info":[{"award-number":["JYTMS20230628"]}],"id":[{"id":"10.13039\/501100007620","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bcp.2025.117518","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:17:06Z","timestamp":1762096626000},"page":"117518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Targeting the C5-C5aR1 axis: A promising therapeutic strategy for Alzheimer\u2019s disease and amyotrophic lateral sclerosis by unlocking neuroprotection"],"prefix":"10.1016","volume":"243","author":[{"given":"Tong-Qi","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Pei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117518_b0005","doi-asserted-by":"crossref","unstructured":"C.A. Alper, A.M. Johnson, A.G. Birtch, F.D. Moore, Human C'3: evidence for the liver as the primary site of synthesis, Science (New York, N.Y.) 163(3864) (1969) 286-8.","DOI":"10.1126\/science.163.3864.286"},{"issue":"3","key":"10.1016\/j.bcp.2025.117518_b0010","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3899\/jrheum.140382","article-title":"The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive","volume":"42","author":"Orlowsky","year":"2015","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117518_b0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nri3761","article-title":"Complement\u2013tapping into new sites and effector systems","volume":"14","author":"Kolev","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117518_b0020","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcp.2025.117518_b0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","article-title":"Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner","volume":"74","author":"Schafer","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2025.117518_b0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev-pathol-031620-113409","article-title":"Complement in Neurologic Disease","volume":"16","author":"Propson","year":"2021","journal-title":"Annu. Rev. Pathol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117518_b0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","article-title":"Complement components of the innate immune system in health and disease in the CNS","volume":"49","author":"Gasque","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.bcp.2025.117518_b0040","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2003.tb03138.x","article-title":"Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection","volume":"992","author":"van Beek","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2025.117518_b0045","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bjp.0707332","article-title":"Function, structure and therapeutic potential of complement C5a receptors","volume":"152","author":"Monk","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117518_b0050","doi-asserted-by":"crossref","unstructured":"X.Q. An, W. Xi, C.Y. Gu, X. Huang, Complement protein C5a enhances the \u03b2-amyloid-induced neuro-inflammatory response in microglia in Alzheimer's disease, Medecine sciences : M\/S 34 Focus issue F1 (2018) 116-120.","DOI":"10.1051\/medsci\/201834f120"},{"key":"10.1016\/j.bcp.2025.117518_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117301","article-title":"G-protein coupled receptors in neuroinflammation, neuropharmacology, and therapeutics","volume":"242","author":"Singh","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117518_b0060","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1074\/jbc.M609178200","article-title":"The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding","volume":"282","author":"Scola","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117518_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110081","article-title":"The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics","volume":"118","author":"Ghosh","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117518_b0070","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2019-001098","article-title":"Selective and marked decrease of complement receptor C5aR2 in human thoracic aortic aneurysms: a dysregulation with potential inflammatory effects","volume":"6","author":"Holt","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.bcp.2025.117518_b0075","doi-asserted-by":"crossref","unstructured":"X.X. Li, R.J. Clark, T.M. Woodruff, C5aR2 Activation Broadly Modulates the Signaling and Function of Primary Human Macrophages, Journal of immunology (Baltimore, Md. : 1950) 205(4) (2020) 1102-1112.","DOI":"10.4049\/jimmunol.2000407"},{"issue":"12","key":"10.1016\/j.bcp.2025.117518_b0080","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1089\/neu.2016.4701","article-title":"The Alternative Receptor for Complement Component 5a, C5aR2, Conveys Neuroprotection in Traumatic Spinal Cord Injury","volume":"34","author":"Biggins","year":"2017","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.bcp.2025.117518_b0085","doi-asserted-by":"crossref","unstructured":"J. Nimmo, R.A.J. Byrne, N. Daskoulidou, L.M. Watkins, S.M. Carpanini, W.M. Zelek, B.P. Morgan, The complement system in neurodegenerative diseases, Clinical science (London, England : 1979) 138(6) (2024) 387-412.","DOI":"10.1042\/CS20230513"},{"issue":"7","key":"10.1016\/j.bcp.2025.117518_b0090","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071812","article-title":"The Complement System: a Powerful Modulator and Effector of Astrocyte Function in the healthy and Diseased Central nervous System","volume":"10","author":"Pekna","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2025.117518_b0095","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1146\/annurev-immunol-101921-035639","article-title":"Complement in the Brain: Contributions to Neuroprotection, Neuronal Plasticity, and Neuroinflammation","volume":"41","author":"Bohlson","year":"2023","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0100","first-page":"1","article-title":"Complement, Arthritis & rheumatology (Hoboken","volume":"76","author":"Monach","year":"2024","journal-title":"N.J.)"},{"key":"10.1016\/j.bcp.2025.117518_b0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1742-2094-10-25","article-title":"Complement activation fragment C5a receptors, CD88 and C5L2, are associated with neurofibrillary pathology","volume":"10","author":"Fonseca","year":"2013","journal-title":"J. Neuroinflammation"},{"issue":"6","key":"10.1016\/j.bcp.2025.117518_b0110","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.immuni.2025.05.003","article-title":"A CD4+ T cell-intrinsic complement C5aR2-prostacyclin-IL-1R2 axis orchestrates Th1 cell contraction","volume":"58","author":"Rahman","year":"2025","journal-title":"Immunity"},{"issue":"16","key":"10.1016\/j.bcp.2025.117518_b0115","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/S0047-6374(01)00311-6","article-title":"Activation of complement and contact system in Alzheimer's disease","volume":"122","author":"Bergamaschini","year":"2001","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.bcp.2025.117518_b0120","doi-asserted-by":"crossref","unstructured":"H. Jiang, D. Burdick, C.G. Glabe, C.W. Cotman, A.J. Tenner, beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain, Journal of immunology (Baltimore, Md. : 1950) 152(10) (1994) 5050-9.","DOI":"10.4049\/jimmunol.152.10.5050"},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0125","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1471-4159.1997.69010388.x","article-title":"Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide","volume":"69","author":"Webster","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2025.117518_b0130","doi-asserted-by":"crossref","unstructured":"I. Farkas, M. Takahashi, A. Fukuda, N. Yamamoto, H. Akatsu, L. Baranyi, H. Tateyama, T. Yamamoto, N. Okada, H. Okada, Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease, Journal of immunology (Baltimore, Md. : 1950) 170(11) (2003) 5764-71.","DOI":"10.4049\/jimmunol.170.11.5764"},{"issue":"15 Suppl","key":"10.1016\/j.bcp.2025.117518_b0135","first-page":"S320","article-title":"Amyotrophic lateral sclerosis: disease state overview","volume":"24","author":"Hulisz","year":"2018","journal-title":"Am. J. Manag. Care"},{"issue":"5","key":"10.1016\/j.bcp.2025.117518_b0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/01376517-200110000-00005","article-title":"Amyotrophic lateral sclerosis: current understanding","volume":"33","author":"Charles","year":"2001","journal-title":"The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses"},{"issue":"7650","key":"10.1016\/j.bcp.2025.117518_b0145","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nature22038","article-title":"Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice","volume":"544","author":"Becker","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2025.117518_b0150","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/jnnp-2021-326553","article-title":"Extensive heterogeneity in patients with ALS with mutations in SOD1 in France","volume":"92","author":"Andersen","year":"2021","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12974-018-1217-2","article-title":"Complement components are upregulated and correlate with disease progression in the TDP-43(Q331K) mouse model of amyotrophic lateral sclerosis","volume":"15","author":"Lee","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"46","key":"10.1016\/j.bcp.2025.117518_b0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1318309110","article-title":"C1q induction and global complement pathway activation do not contribute to ALS toxicity in mutant SOD1 mice","volume":"110","author":"Lobsiger","year":"2013","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bcp.2025.117518_b0165","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.nbd.2011.01.002","article-title":"Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation","volume":"42","author":"Sta","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2025.117518_b0170","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2147\/JIR.S298307","article-title":"Complement Profiles in patients with Amyotrophic Lateral Sclerosis: a prospective Observational Cohort Study","volume":"14","author":"Kj\u00e6ldgaard","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117518_b0175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jneuroim.2014.09.005","article-title":"Elevation of the terminal complement activation products C5a and C5b-9 in ALS patient blood","volume":"276","author":"Mantovani","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bcp.2025.117518_b0180","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1742-2094-10-119","article-title":"Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis","volume":"10","author":"Lee","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.117518_b0185","doi-asserted-by":"crossref","unstructured":"T.M. Woodruff, K.J. Costantini, J.W. Crane, J.D. Atkin, P.N. Monk, S.M. Taylor, P.G. Noakes, The complement factor C5a contributes to pathology in a rat model of amyotrophic lateral sclerosis, Journal of immunology (Baltimore, Md. : 1950) 181(12) (2008) 8727-34.","DOI":"10.4049\/jimmunol.181.12.8727"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2025.117518_b0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jneuroim.2009.01.028","article-title":"The complement factor C5a receptor is upregulated in NFL-\/- mouse motor neurons","volume":"210","author":"Humayun","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13395-017-0128-8","article-title":"Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Wang","year":"2017","journal-title":"Skelet. Muscle"},{"issue":"8","key":"10.1016\/j.bcp.2025.117518_b0200","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bph.13730","article-title":"Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117518_b0205","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0271678X231153281","article-title":"Blood-CNS barrier dysfunction in amyotrophic lateral sclerosis: Proposed mechanisms and clinical implications","volume":"43","author":"Steinruecke","year":"2023","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bcp.2025.117518_b0210","article-title":"Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation","volume":"14","author":"Tang","year":"2023","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117518_b0215","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1681\/ASN.2007111267","article-title":"Complement 5a receptor inhibition improves renal allograft survival","volume":"19","author":"Gueler","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.bcp.2025.117518_b0225","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1471-4159.2010.06595.x","article-title":"Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease","volume":"113","author":"Ager","year":"2010","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.bcp.2025.117518_b0235","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.4049\/jimmunol.181.12.8727","article-title":"The Complement factor C5a contributes to Pathology in a Rat Model of Amyotrophic Lateral Sclerosis1","volume":"181","author":"Woodruff","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13395-017-0128-8","article-title":"Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"7","author":"Wang","year":"2017","journal-title":"Skelet. Muscle"},{"issue":"2","key":"10.1016\/j.bcp.2025.117518_b0220","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0165-5728(99)00261-1","article-title":"The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer's disease","volume":"105","author":"Mukherjee","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bcp.2025.117518_b0230","doi-asserted-by":"crossref","unstructured":"M.I. Fonseca, R.R. Ager, S.H. Chu, O. Yazan, S.D. Sanderson, F.M. LaFerla, S.M. Taylor, T.M. Woodruff, A.J. Tenner, Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease, Journal of immunology (Baltimore, Md. : 1950) 183(2) (2009) 1375-83.","DOI":"10.4049\/jimmunol.0901005"},{"issue":"8","key":"10.1016\/j.bcp.2025.117518_b0240","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bph.13730","article-title":"Pharmacological inhibition of complement C5a-C5a(1) receptor signalling ameliorates disease pathology in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117518_b0250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225417","article-title":"C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar A\u03b2 amyloid and preserves memory in a mouse model of familial Alzheimer's disease","volume":"14","author":"Panayiotou","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.bcp.2025.117518_b0255","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.molimm.2013.06.016","article-title":"IVIG immunotherapy protects against synaptic dysfunction in Alzheimer's disease through complement anaphylatoxin C5a-mediated AMPA-CREB-C\/EBP signaling pathway","volume":"56","author":"Gong","year":"2013","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bcp.2025.117518_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1000183","article-title":"Synaptic dysfunction in ALS and FTD: anatomical and molecular changes provide insights into mechanisms of disease","volume":"15","author":"Gelon","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"14","key":"10.1016\/j.bcp.2025.117518_b0265","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.neuron.2021.05.020","article-title":"C9orf72 deficiency promotes microglial-mediated synaptic loss in aging and amyloid accumulation","volume":"109","author":"Lall","year":"2021","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.bcp.2025.117518_b0270","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/alz.13682","article-title":"C5aR1 signaling promotes region- and age-dependent synaptic pruning in models of Alzheimer's disease","volume":"20","author":"Gomez-Arboledas","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0275","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12974-022-02539-2","article-title":"Modulation of C5a\u2013C5aR1 signaling alters the dynamics of AD progression","volume":"19","author":"Carvalho","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0280","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12974-022-02539-2","article-title":"Modulation of C5a-C5aR1 signaling alters the dynamics of AD progression","volume":"19","author":"Carvalho","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.117518_b0285","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1146\/annurev.iy.12.040194.004015","article-title":"C5A anaphylatoxin and its seven transmembrane-segment receptor","volume":"12","author":"Gerard","year":"1994","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117518_b0290","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1567-5769(00)00038-2","article-title":"Functions of anaphylatoxin C5a in rat liver: direct and indirect actions on nonparenchymal and parenchymal cells","volume":"1","author":"Schieferdecker","year":"2001","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0295","first-page":"31","article-title":"Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system","volume":"150","author":"Gasque","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"32","key":"10.1016\/j.bcp.2025.117518_b0300","doi-asserted-by":"crossref","first-page":"8699","DOI":"10.1523\/JNEUROSCI.2018-07.2007","article-title":"Complement induction in spinal cord microglia results in anaphylatoxin C5a-mediated pain hypersensitivity","volume":"27","author":"Griffin","year":"2007","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2025.117518_b0305","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41422-023-00779-2","article-title":"Mechanism of activation and biased signaling in complement receptor C5aR1","volume":"33","author":"Feng","year":"2023","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0310","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1083\/jcb.200210115","article-title":"Roles of G beta gamma in membrane recruitment and activation of p110 gamma\/p101 phosphoinositide 3-kinase gamma","volume":"160","author":"Brock","year":"2003","journal-title":"J. Cell Biol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117518_b0315","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3892\/etm.2022.11420","article-title":"The complement C3a-C3aR and C5a-C5aR pathways promote viability and inflammation of human retinal pigment epithelium cells by targeting NF-\u03baB signaling","volume":"24","author":"Luo","year":"2022","journal-title":"Exp. Ther. Med."},{"issue":"6","key":"10.1016\/j.bcp.2025.117518_b0320","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2025.117518_b0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113165","article-title":"Complement component 5a receptor 1 and leukotriene B4 receptor 1 regulate neutrophil extracellular trap (NET) formation through Rap1a\/B-Raf\/ERK signaling pathway and their deficiency in term low birth weight newborns leads to deficient NETosis","volume":"142","author":"Das","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117518_b0330","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1074\/jbc.274.2.1124","article-title":"Extracellular signal-regulated kinase 1\/2-mediated phosphorylation of JunD and FosB is required for okadaic acid-induced activator protein 1 activation","volume":"274","author":"Rosenberger","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2025.117518_b0335","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cmi.12071","article-title":"Transcription factor complex AP-1 mediates inflammation initiated by Chlamydia pneumoniae infection","volume":"15","author":"Wang","year":"2013","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.bcp.2025.117518_b0340","doi-asserted-by":"crossref","unstructured":"I.U. Schraufstatter, K. Trieu, L. Sikora, P. Sriramarao, R. DiScipio, Complement c3a and c5a induce different signal transduction cascades in endothelial cells, Journal of immunology (Baltimore, Md. : 1950) 169(4) (2002) 2102-10.","DOI":"10.4049\/jimmunol.169.4.2102"},{"issue":"10","key":"10.1016\/j.bcp.2025.117518_b0345","first-page":"3423","article-title":"Direct recruitment of CRK and GRB2 to VEGFR-3 induces proliferation, migration, and survival of endothelial cells through the activation of ERK","volume":"106","author":"Salameh","year":"2005","journal-title":"AKT, and JNK Pathways, Blood"},{"issue":"2","key":"10.1016\/j.bcp.2025.117518_b0350","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1074\/jbc.274.2.1124","article-title":"Extracellular Signal-regulated Kinase 1\/2-mediated Phosphorylation of JunD and FosB is Required for Okadaic Acid-induced Activator Protein 1 Activation *","volume":"274","author":"Rosenberger","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.bcp.2025.117518_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22063105","article-title":"Complement Regulation in Human Tenocytes under the Influence of Anaphylatoxin C5a","volume":"22","author":"Silawal","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.bcp.2025.117518_b0360","first-page":"7994","article-title":"C5aR antagonist inhibits occurrence and progression of complement C5a induced inflammatory response of microglial cells through activating p38MAPK and ERK1\/2 signaling pathway","volume":"22","author":"Liu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2025.117518_b0365","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12974-015-0369-6","article-title":"Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease","volume":"12","author":"Landlinger","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.117518_b0370","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2014.02.008","article-title":"Complement C5a is detrimental to histological and functional locomotor recovery after spinal cord injury in mice","volume":"66","author":"Li","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2025.117518_b0375","unstructured":"F. Yang, D. Li, S. Xu, [The roles of C5a and C5aR antagonist in TNF-\u03b1 secretion and CD88 expression of BV2 microglial cells treated with A\u03b21-42 oligomer], Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 29(3) (2013) 265-8."},{"issue":"3","key":"10.1016\/j.bcp.2025.117518_b0380","first-page":"571","article-title":"Synapse loss induced by interleukin-1\u03b2 requires pre- and post-synaptic mechanisms, Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune","volume":"7","author":"Mishra","year":"2012","journal-title":"Pharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2025.117518_b0385","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41419-021-03465-6","article-title":"Neuroinflammation induces synaptic scaling through IL-1\u03b2-mediated activation of the transcriptional repressor REST\/NRSF","volume":"12","author":"Buffolo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.117518_b0390","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41421-020-0143-5","article-title":"Tumor necrosis factor alpha mediates neuromuscular synapse elimination","volume":"6","author":"Fu","year":"2020","journal-title":"Cell Discovery"},{"issue":"4","key":"10.1016\/j.bcp.2025.117518_b0395","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1523\/JNEUROSCI.2235-16.2016","article-title":"TNF-\u03b1 Differentially Regulates Synaptic Plasticity in the Hippocampus and Spinal Cord by Microglia-Dependent Mechanisms after Peripheral Nerve Injury","volume":"37","author":"Liu","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117518_b0400","doi-asserted-by":"crossref","unstructured":"M. Stampanoni Bassi, E. Iezzi, F. Mori, I. Simonelli, L. Gilio, F. Buttari, F. Sica, N. De Paolis, G. Mandolesi, A. Musella, F. De Vito, E. Dolcetti, A. Bruno, R. Furlan, A. Finardi, G.A. Marfia, D. Centonze, F.R. Rizzo, Interleukin-6 Disrupts Synaptic Plasticity and Impairs Tissue Damage Compensation in Multiple Sclerosis, Neurorehabilitation and neural repair 33(10) (2019) 825-835.","DOI":"10.1177\/1545968319868713"},{"key":"10.1016\/j.bcp.2025.117518_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156370","article-title":"Inhibition of C5aR1 as a promising approach to treat taxane-induced neuropathy","volume":"171","author":"Cristiano","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2025.117518_b0610","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bbi.2019.08.004","article-title":"Complement activation sustains neuroinflammation and deteriorates adult neurogenesis and spatial memory impairment in rat hippocampus following sleep deprivation","volume":"82","author":"Wadhwa","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"8","key":"10.1016\/j.bcp.2025.117518_b0615","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1007\/s12035-016-0141-7","article-title":"C5a\/C5aR Pathway Plays a Vital Role in Brain Inflammatory Injury via Initiating Fgl-2 in Intracerebral Hemorrhage","volume":"54","author":"Yuan","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2025.117518_b0425","doi-asserted-by":"crossref","unstructured":"P.F. Stahel, K. Frei, H.P. Eugster, A. Fontana, K.M. Hummel, R.A. Wetsel, R.S. Ames, S.R. Barnum, TNF-alpha-mediated expression of the receptor for anaphylatoxin C5a on neurons in experimental Listeria meningoencephalitis, Journal of immunology (Baltimore, Md. : 1950) 159(2) (1997) 861-9.","DOI":"10.4049\/jimmunol.159.2.861"},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0405","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12890-021-01464-z","article-title":"Nuclear factor-kappaB regulates the transcription of NADPH oxidase 1 in human alveolar epithelial cells","volume":"21","author":"Wu","year":"2021","journal-title":"BMC Pulm. Med."},{"issue":"11","key":"10.1016\/j.bcp.2025.117518_b0410","article-title":"Microglial Dysfunction in Neurodegenerative Diseases via RIPK1 and ROS, Antioxidants (Basel","volume":"11","author":"Wu","year":"2022","journal-title":"Switzerland)"},{"key":"10.1016\/j.bcp.2025.117518_b0415","article-title":"The role of redox-mediated lysosomal dysfunction and therapeutic strategies","volume":"165","author":"He","year":"2023","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.bcp.2025.117518_b0420","doi-asserted-by":"crossref","unstructured":"O. Scott, E. Saran, S.A. Freeman, The spectrum of lysosomal stress and damage responses: from mechanosensing to inflammation, EMBO reports 26(6) (2025) 1425-1439-1439.","DOI":"10.1038\/s44319-025-00405-9"},{"issue":"Pt A","key":"10.1016\/j.bcp.2025.117518_b0430","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.arr.2015.03.003","article-title":"DAMPs activating innate immune responses in sepsis","volume":"24","author":"Kang","year":"2015","journal-title":"Ageing Res. Rev."},{"issue":"9","key":"10.1016\/j.bcp.2025.117518_b0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094675","article-title":"Aberrant Complement System Activation in Neurological Disorders","volume":"22","author":"Ziabska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.117518_b0440","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1034\/j.1600-065X.2001.1800104.x","article-title":"Role of the C5b-9 complement complex in cell cycle and apoptosis","volume":"180","author":"Rus","year":"2001","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2025.117518_b0445","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/07853890510007278","article-title":"C5b-9 complement complex in autoimmune demyelination and multiple sclerosis: dual role in neuroinflammation and neuroprotection","volume":"37","author":"Rus","year":"2005","journal-title":"Ann. Med."},{"issue":"4","key":"10.1016\/j.bcp.2025.117518_b0450","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.3892\/mmr.2016.4948","article-title":"Role of neuroinflammation in neurodegenerative diseases (Review)","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0455","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0460","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1186\/s12974-018-1333-z","article-title":"Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica","volume":"15","author":"Duan","year":"2018","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.bcp.2025.117518_b0465","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41419-023-05783-3","article-title":"Multiple sclerosis plasma IgG aggregates induce complement-dependent neuronal apoptosis","volume":"14","author":"Zhou","year":"2023","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bcp.2025.117518_b0470","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12975-015-0388-8","article-title":"Iron-induced necrotic brain cell death in rats with different aerobic capacity","volume":"6","author":"Zheng","year":"2015","journal-title":"Transl. Stroke Res."},{"issue":"3","key":"10.1016\/j.bcp.2025.117518_b0475","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1523\/JNEUROSCI.23-03-00955.2003","article-title":"Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration","volume":"23","author":"Xiong","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117518_b0480","doi-asserted-by":"crossref","unstructured":"K. Fluiter, A.L. Opperhuizen, B.P. Morgan, F. Baas, V. Ramaglia, Inhibition of the membrane attack complex of the complement system reduces secondary neuroaxonal loss and promotes neurologic recovery after traumatic brain injury in mice, Journal of immunology (Baltimore, Md. : 1950) 192(5) (2014) 2339-48.","DOI":"10.4049\/jimmunol.1302793"},{"key":"10.1016\/j.bcp.2025.117518_b0485","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1742-2094-7-24","article-title":"Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury","volume":"7","author":"Wang","year":"2010","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.bcp.2025.117518_b0490","first-page":"305","article-title":"Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and in immunotherapy of human malignancies (Review)","volume":"13","author":"Maio","year":"1998","journal-title":"Int. J. Oncol."},{"issue":"3\u20134","key":"10.1016\/j.bcp.2025.117518_b0495","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/1380-2933(95)00018-6","article-title":"CD59: its role in complement regulation and potential for therapeutic use","volume":"1","author":"Sugita","year":"1995","journal-title":"Immunotechnology : an International Journal of Immunological Engineering"},{"issue":"5","key":"10.1016\/j.bcp.2025.117518_b0500","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1046\/j.1523-1755.1998.00130.x","article-title":"Complement regulatory proteins in glomerular diseases","volume":"54","author":"Nangaku","year":"1998","journal-title":"Kidney Int."},{"issue":"2","key":"10.1016\/j.bcp.2025.117518_b0505","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/joim.12606","article-title":"The role of complement inhibitors beyond controlling inflammation","volume":"282","author":"Blom","year":"2017","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0510","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuron.2014.11.018","article-title":"NF\u03baB-Activated Astroglial Release of Complement C3 compromises Neuronal Morphology and Function Associated with Alzheimer\u2019s Disease","volume":"85","author":"Lian","year":"2015","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.bcp.2025.117518_b0515","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp. Neurol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0520","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12974-016-0538-2","article-title":"Complement activation at the motor end-plates in amyotrophic lateral sclerosis","volume":"13","author":"Bahia El Idrissi","year":"2016","journal-title":"J. Neuroinflammation"},{"issue":"20","key":"10.1016\/j.bcp.2025.117518_b0525","doi-asserted-by":"crossref","first-page":"7505","DOI":"10.1523\/JNEUROSCI.20-20-07505.2000","article-title":"Deficiency of complement defense protein CD59 may contribute to neurodegeneration in Alzheimer's disease","volume":"20","author":"Yang","year":"2000","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0530","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/tpj.2009.52","article-title":"Upregulating CD59: a new strategy for protection of neurons from complement-mediated degeneration","volume":"10","author":"Kolev","year":"2010","journal-title":"Pharmacogenomics J"},{"issue":"3","key":"10.1016\/j.bcp.2025.117518_b0535","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/nbdi.1996.0020","article-title":"Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions","volume":"3","author":"Pasinetti","year":"1996","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.bcp.2025.117518_b0540","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0306-4522(98)00372-8","article-title":"Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration","volume":"88","author":"Osaka","year":"1999","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.bcp.2025.117518_b0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpsgos.2024.100306","article-title":"Complement C5a Receptor Signaling Alters stress Responsiveness and Modulates Microglia following Chronic stress Exposure","volume":"4","author":"Chen","year":"2024","journal-title":"Biological Psychiatry Global Open Science"},{"issue":"5","key":"10.1016\/j.bcp.2025.117518_b0550","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1038\/s41591-025-03574-1","article-title":"Microglial mechanisms drive amyloid-\u03b2 clearance in immunized patients with Alzheimer\u2019s disease","volume":"31","author":"van Olst","year":"2025","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0555","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.117518_b0560","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2202-12-91","article-title":"A comparison of in vitro properties of resting SOD1 transgenic microglia reveals evidence of reduced neuroprotective function","volume":"12","author":"Sargsyan","year":"2011","journal-title":"BMC Neurosci."},{"issue":"10","key":"10.1016\/j.bcp.2025.117518_b0565","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1523\/JNEUROSCI.4998-04.2005","article-title":"Beta-amyloid-stimulated microglia induce neuron death via synergistic stimulation of tumor necrosis factor alpha and NMDA receptors","volume":"25","author":"Floden","year":"2005","journal-title":"J. Neurosci."},{"issue":"46","key":"10.1016\/j.bcp.2025.117518_b0570","doi-asserted-by":"crossref","first-page":"40151","DOI":"10.1074\/jbc.M111.279711","article-title":"Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity","volume":"286","author":"Li","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0575","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-017-0210-z","article-title":"Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss","volume":"12","author":"Hernandez","year":"2017","journal-title":"Mol. Neurodegener."},{"issue":"1","key":"10.1016\/j.bcp.2025.117518_b0580","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s40265-021-01643-6","article-title":"Avacopan: first Approval","volume":"82","author":"Lee","year":"2022","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.bcp.2025.117518_b0585","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1474-4422(23)00080-7","article-title":"Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study","volume":"22","author":"Howard","year":"2023","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117518_b0590","first-page":"582","article-title":"Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in patients with Moderate to Severe Generalized Myasthenia Gravis: results of a phase 2 Randomized","volume":"77","author":"Howard","year":"2020","journal-title":"Double-Blind, Placebo-Controlled, Multicenter Clinical Trial, JAMA Neurol"},{"issue":"5","key":"10.1016\/j.bcp.2025.117518_b0595","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S1474-4422(23)00125-4","article-title":"New therapies for autoimmune myasthenia gravis","volume":"22","author":"Verschuuren","year":"2023","journal-title":"The Lancet Neurology"},{"issue":"4","key":"10.1016\/j.bcp.2025.117518_b0600","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040399","article-title":"Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives","volume":"9","author":"Giorgio","year":"2021","journal-title":"Biomedicines"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500783X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522500783X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:04:18Z","timestamp":1775797458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522500783X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":123,"alternative-id":["S000629522500783X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117518","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the C5-C5aR1 axis: A promising therapeutic strategy for Alzheimer\u2019s disease and amyotrophic lateral sclerosis by unlocking neuroprotection","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117518"}}